Of the 34 matched samples with concordant alterations in tumor tissue DNA and sputum cfDNA, alterations were found as follows: EGFR (44%), TP53 (53%), CTNNB1 (12%), and RB1 (12%). This evidence concerns the gene EGFR and neoplasm.